Pegunigalsidase Alfa
Records for this ingredient, by country (identity only).
ATC A16AB20 · 7 markets · 12 records
AU 3 records · 2 shown of 2
- 20 mg/10 mLinjectionELFABRIO
- 20 mg per mL / per unit basis not statedinjectionELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 2 records · 2 shown of 2
- 20 mg/10 mLinjectionElfabrio 20mg/10ml concentrate for solution for infusion vials
- 5 mg/2.5 mLinjectionElfabrio 20mg/10ml concentrate for solution for infusion vials
CA 2 records · 1 shown of 1
- 2 mg/1 mLliquidELFABRIO
SG 1 records · 1 shown of 1
- 2 mg/mL per mL / per unit basis not statedinjectionElfabrio Concentrate for Solution for Infusion 2 mg/ml
TW 1 records · 1 shown of 1
- 2 mg per mL / per unit basis not statedinjectionElfabrio 2 mg/mL concentrate for solution for infusion翡立柏濃縮注射液2毫克/毫升
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | TW | EU |
|---|---|---|---|---|---|---|---|
| 20 mg/10 mL injection | ELFABRIO | Elfabrio 20mg/10ml concentrate for solution for infusion vials | ELFABRIO | ||||
| 5 mg/2.5 mL injection | ELFABRIO | Elfabrio 20mg/10ml concentrate for solution for infusion vials | |||||
| 2 mg per mL / per unit basis not stated cannot compare injection | Elfabrio 2 mg/mL concentrate for solution for infusion 翡立柏濃縮注射液2毫克/毫升 | ||||||
| 2 mg/1 mL liquid | ELFABRIO | ||||||
| 20 mg per mL / per unit basis not stated cannot compare injection | ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial | ||||||
| 2 mg/mL per mL / per unit basis not stated cannot compare injection | Elfabrio Concentrate for Solution for Infusion 2 mg/ml | ||||||
unknown | ELFABRIO | ELFABRIO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · SG · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · TW 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 CA · SG · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.